{"id":10361,"date":"2022-01-11T07:48:59","date_gmt":"2022-01-11T06:48:59","guid":{"rendered":"https:\/\/thesmartcityjournal.cibeles.net\/sin-categoria\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\/"},"modified":"2022-01-10T17:06:10","modified_gmt":"2022-01-10T16:06:10","slug":"mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","status":"publish","type":"post","link":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","title":{"rendered":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment"},"content":{"rendered":"

Applying patient data that included genomic, clinical and demographic information, researchers used AI to determine an initial response to methotrexate in patients with early-stage rheumatoid arthritis<\/em><\/p>\n

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic<\/strong> researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research<\/strong>.<\/p>\n

The study focused on predicting the response to methotrexate, one of the most common rheumatoid arthritis medications. Applying patient data that included genomic, clinical and demographic information, researchers used AI to determine an initial response to methotrexate in patients with early-stage rheumatoid arthritis. Data used in the study came from a collaboration between Mayo Clinic<\/strong> and the Pharmacogenetics of Methotrexate in Rheumatoid Arthritis<\/strong> (PAMERA) consortium, that led to early genome-wide association studies.<\/p>\n

This work evolved from the union of AI and pharmacogenomics co-led by Liewei Wang; M.D., Ph.D., Arjun Athreya, Ph.D. and Richard Weinshilboum, M.D.<\/strong> “This approach began by developing tools to predict drug treatment outcomes in major depressive disorder, but we are delighted to see that it can potentially be applied widely, in this case to the drug therapy of rheumatoid arthritis,” says pharmacogenomics leaders Drs. Wang and Weinshilboum<\/strong>.<\/p>\n

“In my everyday practice, patients frequently ask, ‘What medication will be most effective for me’ or ‘What is the chance this medication will help?’ This is a study that seeks to address these questions,” says Elena Myasoedova, M.D., Ph.D., a Mayo Clinic rheumatologist and lead author<\/strong>. By predicting a response to methotrexate, researchers identified which patients are most likely to benefit from this medication in the first three months of treatment.<\/p>\n

More research is needed to understand how these findings can be used in practice. The study, which is part of a series looking at the roles of AI and pharmacogenomics in treating rheumatoid arthritis, was performed in collaboration with Mayo Clinic’s Center for Individualized Medicine<\/strong>.<\/p>\n

“Predicting a response to rheumatoid arthritis medication can be challenging, but this approach is very promising and is an exciting development in treating the disease,” Dr. Myasoedova<\/strong> says.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Applying patient data that included genomic, clinical and demographic information, researchers used AI to determine an initial response to methotrexate in patients with early-stage rheumatoid arthritis Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how\u2026<\/p>\n","protected":false},"author":2,"featured_media":10360,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_scj_primary_category_id":88,"_scj_featured":false,"_scj_featured_from":"","_scj_featured_until":"","_scj_featured_order":0,"_scj_visibility_class":"current","_scj_layout_family":"standard","_scj_article_style":"","_scj_display_overrides":[],"_scj_intro_image_id":10360,"_scj_intro_alt":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment","_scj_intro_caption":"","_scj_intro_class":"","_scj_intro_float":"","_scj_full_image_id":10360,"_scj_full_alt":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment","_scj_full_caption":"","_scj_full_class":"","_scj_full_float":"","_scj_media_type":"","_scj_media_provider":"","_scj_media_external_id":"","_scj_media_url":"","_scj_media_poster_id":0,"_scj_media_width":0,"_scj_media_height":0,"_scj_media_aspect_ratio":"","_scj_media_description":"","_scj_gallery_items":[],"_scj_related_post_ids":[],"_scj_additional_authors":[],"scj_layout_family":"standard","scj_media_provider":"","scj_media_url":"","scj_full_caption":"","footnotes":""},"categories":[88],"tags":[],"class_list":["post-10361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-smart-health"],"yoast_head":"\nMayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com<\/title>\n<meta name=\"description\" content=\"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com\" \/>\n<meta property=\"og:description\" content=\"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\" \/>\n<meta property=\"og:site_name\" content=\"thesmartcityjournal.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thesmartcityjournal\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-11T06:48:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:site\" content=\"@SmartCityJour_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n de The Smart City Journal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\"},\"author\":{\"@type\":\"Organization\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/author\\\/smart-city\"},\"headline\":\"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment\",\"datePublished\":\"2022-01-11T06:48:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\"},\"wordCount\":375,\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/AI_and_pharmacogenomics.jpg\",\"articleSection\":[\"Smart Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\",\"name\":\"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/AI_and_pharmacogenomics.jpg\",\"datePublished\":\"2022-01-11T06:48:59+00:00\",\"description\":\"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/AI_and_pharmacogenomics.jpg\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/AI_and_pharmacogenomics.jpg\",\"width\":1280,\"height\":800,\"caption\":\"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/smart-health\\\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#website\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\",\"name\":\"thesmartcityjournal.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"NewsMediaOrganization\"],\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#organization\",\"name\":\"thesmartcityjournal.com\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"contentUrl\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo-smart-city-journal-1.png\",\"width\":346,\"height\":91,\"caption\":\"thesmartcityjournal.com\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/thesmartcityjournal\",\"https:\\\/\\\/x.com\\\/SmartCityJour_\",\"https:\\\/\\\/www.instagram.com\\\/thesmartcityjournal_\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@thesmartcityjournal\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/the-smart-city-journal\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIPTMzK206pVFxMNjO7SSxw\"]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#\\\/schema\\\/person\\\/39c9da1aeac1b5c2d179ef9e4e293cf4\",\"name\":\"Redacci\u00f3n de The Smart City Journal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n de The Smart City Journal\"},\"description\":\"Equipo de redacci\u00f3n de The Smart City Journal.\",\"url\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en\\\/author\\\/smart-city\"},{\"@type\":\"SiteNavigationElement\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#site-navigation\",\"cssSelector\":[\".cib-main-menu\"]},{\"@type\":\"WPHeader\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#header\",\"cssSelector\":[\".cib-header\"]},{\"@type\":\"WPFooter\",\"@id\":\"https:\\\/\\\/www.thesmartcityjournal.com\\\/en#footer\",\"cssSelector\":[\".cib-footer\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com","description":"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","og_locale":"en_US","og_type":"article","og_title":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com","og_description":"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.","og_url":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","og_site_name":"thesmartcityjournal.com","article_publisher":"https:\/\/www.facebook.com\/thesmartcityjournal","article_published_time":"2022-01-11T06:48:59+00:00","og_image":[{"width":1280,"height":800,"url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n de The Smart City Journal","twitter_card":"summary_large_image","twitter_creator":"@SmartCityJour_","twitter_site":"@SmartCityJour_","twitter_misc":{"Written by":"Redacci\u00f3n de The Smart City Journal","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#article","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment"},"author":{"@type":"Organization","name":"Redacci\u00f3n de The Smart City Journal","url":"https:\/\/www.thesmartcityjournal.com\/en\/author\/smart-city"},"headline":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment","datePublished":"2022-01-11T06:48:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment"},"wordCount":375,"publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg","articleSection":["Smart Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","url":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment","name":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment - thesmartcityjournal.com","isPartOf":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage"},"thumbnailUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg","datePublished":"2022-01-11T06:48:59+00:00","description":"Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.","breadcrumb":{"@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#primaryimage","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2022\/01\/AI_and_pharmacogenomics.jpg","width":1280,"height":800,"caption":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/www.thesmartcityjournal.com\/en\/smart-health\/mayo-clinic-researchers-use-ai-biomarkers-to-personalize-rheumatoid-arthritis-treatment#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thesmartcityjournal.com\/en"},{"@type":"ListItem","position":2,"name":"Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment"}]},{"@type":"WebSite","@id":"https:\/\/www.thesmartcityjournal.com\/en#website","url":"https:\/\/www.thesmartcityjournal.com\/en","name":"thesmartcityjournal.com","description":"","publisher":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thesmartcityjournal.com\/en?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","NewsMediaOrganization"],"@id":"https:\/\/www.thesmartcityjournal.com\/en#organization","name":"thesmartcityjournal.com","url":"https:\/\/www.thesmartcityjournal.com\/en","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/logo\/image\/","url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","contentUrl":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2026\/09\/logo-smart-city-journal-1.png","width":346,"height":91,"caption":"thesmartcityjournal.com"},"image":{"@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thesmartcityjournal","https:\/\/x.com\/SmartCityJour_","https:\/\/www.instagram.com\/thesmartcityjournal_\/","https:\/\/www.tiktok.com\/@thesmartcityjournal","https:\/\/www.linkedin.com\/company\/the-smart-city-journal\/","https:\/\/www.youtube.com\/channel\/UCIPTMzK206pVFxMNjO7SSxw"]},{"@type":"Organization","@id":"https:\/\/www.thesmartcityjournal.com\/en#\/schema\/person\/39c9da1aeac1b5c2d179ef9e4e293cf4","name":"Redacci\u00f3n de The Smart City Journal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Redacci\u00f3n de The Smart City Journal"},"description":"Equipo de redacci\u00f3n de The Smart City Journal.","url":"https:\/\/www.thesmartcityjournal.com\/en\/author\/smart-city"},{"@type":"SiteNavigationElement","@id":"https:\/\/www.thesmartcityjournal.com\/en#site-navigation","cssSelector":[".cib-main-menu"]},{"@type":"WPHeader","@id":"https:\/\/www.thesmartcityjournal.com\/en#header","cssSelector":[".cib-header"]},{"@type":"WPFooter","@id":"https:\/\/www.thesmartcityjournal.com\/en#footer","cssSelector":[".cib-footer"]}]}},"_links":{"self":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts\/10361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/comments?post=10361"}],"version-history":[{"count":0,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/posts\/10361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/media\/10360"}],"wp:attachment":[{"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/media?parent=10361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/categories?post=10361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thesmartcityjournal.com\/en\/wp-json\/wp\/v2\/tags?post=10361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}